City

Austin (1)

Palo Alto (1)

Shanghai (1)

Condition

Retinal Drusen (3)

Macular Degeneration (2)

Age-related Macular Degeneration (1)

Geographic Atrophy (1)

Wet Macular Degeneration (1)

Overall Status

Completed (3)

Sign in for free

Phase

n/a (2)

Sponsor

Guardion Health Sciences, Inc. (1)

Shanghai University of Traditional Chinese Medicine (1)

Stanford University (1)

Collaborator

Bascom Palmer Eye Institute (1)

Eye Clinic of Austin (1)

Western University of Health Sciences (1)

Intervention

areds2 (1)

follow-up observation (1)

lumega-z (1)

pascal retinal laser photocoagulator (1)

Study Documents

Intervention Type

device (1)

dietary supplement (1)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

retinal drusen

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Macular Degeneration, Retinal Drusen Trial in Palo Alto (Pascal Retinal Laser Photocoagulator)

Completed

Has Results

Macular Degeneration
Retinal Drusen

Pascal Retinal Laser Photocoagulator

Palo Alto, California

Byers Eye Institute at Stanford University

Oct 13, 2021

Retinal Drusen, Age-related Macular Degeneration, Macular Degeneration Trial in Austin (Lumega-Z, AREDS2)

Completed

Retinal Drusen
+2 more

Lumega-Z
AREDS2

Austin, Texas

Eye Clinic of Austin

May 9, 2019

Macular Choroidal Neovascularization in a Chinese Population

Completed

Geographic Atrophy
+2 more

Follow-up observation

Shanghai, Baoshan District, China

Youyi Street

Aug 14, 2012